SATTARZADEH SHERWIN (Chief Operating Officer) received a stock award from DAMORA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/26/2026ACC: 0001193125-26-023094
Officer· Chief Operating Officer
Since Jan 2026
+634.59K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
634.59K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+190.38K
Price / share
—
Trade value
—
% of position
New position
1/5/2026
0.00→190.38K
Total
Net shares
+190.38K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2026 | A · Award | +190.38K | — | — | New position | 0.00 | 190.38K |
| Total | +190.38K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
444.21K shares
Shares
+444.21K
Strike price
21.82
Held after
444.21K
Exercisable
—
1/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock444.21K shares | 1/5/2026 | A · Award | +444.21K | 21.82 | — | 444.21K |